10. Fedintsev A., Kashtanova D., Tkacheva O. et al. Markers of arterial health could serve as accurate non-invasive predictors of human biological and chronological age. Aging (Albany NY). 2017;9(4):1280–1292. doi: 10.18632/aging.101227. www.ncbi.nlm. nih.gov/pubmed/28455973 (дата обращения: 08.01.2021).
11. Батин М., Веремеенко Д. Диагностика старения. М.; 2018. (Электронный ресурс) URL: https://nestarenie.ru/Diagnostika.pdf (дата обращения: 08.01.2021).
12. Feairheller D.L., Diaz K.M., Kashem M.A. et al. Effects of moderate aerobic exercise training on vascular health and blood pressure in African Americans. J Clin Hypertens (Greenwich). 2014;16(7):504–510. doi: 10.1111/jch.12328. https://pubmed.ncbi.nlm. nih.gov/24779748 (дата обращения: 08.01.2021).
13. Gielen S., Laughlin M.H., O’Conner C., Duncker D.J. Exercise training in patients with heart disease: review of beneficial effects and clinical recommendations. Prog Cardiovasc Dis. 2015;57(4):347-55. doi: 10.1016/j.pcad.2014.10.001. https://pubmed. ncbi.nlm.nih.gov/25459973 (дата обращения: 08.01.2021)..
14. Taylor R.S., Brown A., Ebrahim S., Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004;116(10):682–692. DOI: 10.1016/j.amjmed.2004.01.009. www. ncbi.nlm.nih.gov/pubmed/15121495 (дата обр. 08.01.2021).
15. Heran B.S., Chen J.M., Ebrahim S. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2011;(7):CD001800. doi: 10.1002/14651858.CD001800.pub2. www.ncbi.nlm.nih.gov/pubmed/21735386 (дата обращения: 08.01.2021).
16. Carvalheira-Dos-Santos R., Delgado R.M., Ferreira-Dos-Santos G, Vaz-Carneiro A. Analysis of the Cochrane Review: Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease. Acta Med Port. 2019;32(7–8):483–487. doi: 10.20344/amp.11898. www. ncbi.nlm.nih.gov/pubmed/31445527 (дата обращения: 08.01.2021).
17. Boden W.E., O’Rourke R.A., Teo K.K. et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):15°3-1516. DOI: 10.1056/NEJMoa070829. https://pubmed.ncbi.nlm.nih.gov/17387127 (дата обращения: 08.01.2021).
18. Shaw L.J., Berman D.S., Maron D.J. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117(10):1283-91. doi: 10.1161/ CiRCULATIONAHA.107.743963. https://pubmed.ncbi.nlm.nih.gov/18268144/ (дата обращения: 08.01.2021).
19. Hambrecht R., Niebauer J., Marburger C. et al. Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol. 1993;22(2):468–477. doi: 10.1016/0735-1097(93)90051-2. https://pubmed.ncbi. nlm.nih.gov/8335816/ (дата обращения: 08.01.2021).
20. Turner J.E. Is immunosenescence influenced by our lifetime “dose” of exercise? Biogerontology. 2016;17(3):581–602. doi: 10.1007/s10522-016-9642-z. https://pubmed. ncbi.nlm.nih.gov/27023222/ (дата обращения: 08.01.2021).
21. Schnohr P., O’Keefe J.H., Marott J.L et al. Dose of jogging and long-term mortality: the Copenhagen City Heart Study. J Am Coll Cardiol. 2015;65(5):411-9. doi: 10.1016/j. jacc.2014.11.023. https://pubmed.ncbi.nlm.nih.gov/25660917/ (дата обращения: 08.01.2021).
22. Wang N., Zhang X., Xiang Y.-B. Associations of Tai Chi, Walking, and Jogging With Mortality in Chinese Men. Am J Epidemiol. 2013; 178(5):791–796. doi: 10.1093/aje/kwt050. https://pubmed.ncbi.nlm.nih.gov/23813700/ (дата обращения: 08.01.2021).
23. Li Y., Pan A., Wang D.D. et al. Impact of Healthy Lifestyle Factors on Life Expectancies in the US Population. Circulation. 2018;138(4):345–355. doi: 10.1161/ CiRcULATIONAHA.117.032047. https://pubmed.ncbi.nlm.nih.gov/29712712/ (дата обращения: 08.01.2021).
24. Pal S., Radavelli-Bagatini S., Ho S. Potential benefits of exercise on blood pressure and vascular function. J Am Soc Hypertens. 2013;7(6):494–506. doi: 10.1016/j. jash.2013.07.004. https://pubmed.ncbi.nlm.nih.gov/23992766/ (дата обращения: 08.01.2021).
25. Nes B.M., Janszky I., Wisloff U. et al. Age-predicted maximal heart rate in healthy subjects: The HUNT fitness study. Scand J Med Sci Sports. 2013;23(6):697–704. doi: 10.1111/j.1600–0838.2012.01445.x. https://pubmed.ncbi.nlm.nih.gov/22376273/ (дата обращения: 08.01.2021).
26. Ruiz J.R., Joyner M., Lucia A. CrossTalk opposing view: Prolonged intense exercise does not lead to cardiac damage. J Physiol. 2013; 591(Pt 20): 4943–4945. doi: 10.1113/jphysiol.2013.257147. https://pubmed.ncbi.nlm.nih.gov/24130314/ (дата обращения: 08.01.2021).
27. Ho T.J., Huang C.C., Huang C.Y., Lin W.T. Fasudil, a Rho-kinase inhibitor, protects against excessive endurance exercise training-induced cardiac hypertrophy, apoptosis and fibrosis in rats. Eur J Appl Physiol. 2012;112(8):2943-55. doi: 10.1007/s00421-011-2270-z. https://www.springermedizin.de/fasudil-a-rho-kinase-inhibitor-protects-against-excessive-endura/8483858 (дата обращения: 08.01.2021).
28. Рисунок 8. (Электронный ресурс) URL: https://www.shutterstock.ru.
29. Wasfy M.M., Hutter A.M., Weiner R.B. Sudden Cardiac Death in Athletes. Methodist Debakey Cardiovasc J. 2016;12(2):76–80. doi: 10.14797/mdcj-12-2-76. https://pubmed.ncbi.nlm.nih.gov/27486488 (дата обращения: 08.01.2021).
30. Российская газета. (Электронный ресурс) URL: https://rg.ru/2008/10/15/ cherepanov.html (дата обращения: 08.12.2021).
31. O’Keefe J.H., Patil H.R., Lavie C.J. et al. Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc. 2012;87(6):587-95. doi: 10.1016/j. mayocp.2012.04.005. https://pubmed.ncbi.nlm.nih.gov/22677079 (дата обращения: 08.12.2021).
32. Breuckmann F., Mohlenkamp S., Nassenstein K. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology. 2009 Apr;251(1):50-7. doi: 10.1148/radiol.2511081118. www.ncbi.nlm. nih.gov/pubmed/19332846 (дата обращения: 08.01.2021).
33. Agabiti-Rosei E., Mancia G., O’Rourke M.F. et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension. 2007 Jul;50(1):154-60. doi: 10.1161/HYPERTENSIONAHA.107.090068. www.ncbi. nlm.nih.gov/pubmed/17562972 (дата обращения: 08.01.2021).
34. Vlachopoulos Ch., Kardara D., Anastasakis A. et al. Arterial stiffness and wave reflections in marathon runners. Am J Hypertens. 2010 Sep;23(9):974-9. doi: 10.1038/ ajh.2010.99. www.ncbi.nlm.nih.gov/pubmed/20489686 (дата обращения: 08.01.2021).
35. Benjamin E.J., Wolf P.A., D’Agostino R.B. et al.Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998 Sep 8;98(10):946-52. doi: 10.1161/01.cir.98.10.946. www.ncbi.nlm.nih.gov/pubmed/9737513 (дата обращения: 08.01.2021).
36. Guasch E., Nattel S. CrossTalk proposal: Prolonged intense exercise training does lead to myocardial damage. J Physiol. 2013 Oct 15;591(20):4939-41. doi: 10.1113/ jphysiol.2013.257238. www.ncbi.nlm.nih.gov/pubmed/24130313 (дата обращения: 08.01.2021).
37. Lin Y., Gajewski A., Poznanska A. Examining mortality risk and rate of ageing among Polish Olympic athletes: a survival follow-up from 1924 to 2012. BMJ Open. 2016 Apr 18;6(4):e010965. doi: 10.1136/bmjopen-2015-010965. www.ncbi.nlm.nih. gov/pubmed/27091824 (дата обращения: 08.01.2021).
38. Radonic V., Kozmar D., Pocanic D. et al. Mortality and causes of death among Croatian male Olympic medalists. Croat Med J. 2017 Aug 31;58(4):263–269. doi: 10.3325/ cmj.2017.58.263. www.ncbi.nlm.nih.gov/pubmed/28857519 (дата обращения: 08.01.2021).
39. Lemez S., Baker J. Do Elite Athletes Live Longer? A Systematic Review of Mortality and Longevity in Elite Athletes. Sports Med Open. 2015;1(1):16. doi: 10.1186/s40798-015-0024-x. www.ncbi.nlm.nih.gov/pubmed/26301178 (дата обращения: 08.01.2021).
40. Garatachea N., Lucia A. Genes, physical fitness and ageing. Ageing Res Rev. 2013 Jan;12(1):90-102. doi: 10.1016/j.arr.2012.09.003. www.ncbi.nlm.nih.gov/ pubmed/23022740 (дата обращения: 08.01.2021).
41. Fogelholm M., Kaprio J., Sarna S. Healthy lifestyles of former Finnish world class athletes. Med Sci Sports Exerc. 1994 Feb;26(2):224-9. doi: 10.1249/00005768199402000-00013. www.ncbi.nlm.nih.gov/pubmed/8164540 (дата обращения: 08.01.2021).
42. Kettunen J., Kujala U.A., Kaprio J. et al. All-cause and disease-specific mortality among male, former elite athletes: an average 50-year follow-up. Br J Sports Med. 2015 Jul;49(13):893-7. doi: 10.1136/bjsports-2013-093347. www.ncbi.nlm.nih.gov/ pubmed/25183628 (дата обращения: 08.01.2021).
43. Kontro T.K., Sarna S., Kaprio J., Kujala U.M. Mortality and health-related habits in 900 Finnish former elite athletes and their brothers. Br J Sports Med. 2018 Jan;52(2):89–95. doi: 10.1136/bjsports-2017-098206. www.ncbi.nlm.nih.gov/pubmed/29127265 (дата обращения: 08.01.2021).
44. Gajda J., Smigielski W., Smigielski J. et al. Longevity and cardiovascular mortality of Polish elite football players. Kardiol Pol. 2018;76(12):1705–1711. doi: 10.5603/KP.a2018.0173. www.ncbi.nlm.nih.gov/pubmed/30091130 (дата обращения: 08.01.2021).
45. Stensvold D., Viken H., Steinshamn S.L. et al. Effect of exercise training for five years on all cause mortality in older adults-the Generation 100 study: randomised controlled trial. BMJ. 2020 Oct 7;371:m3485. doi: 10.1136/bmj.m3485. www.ncbi.nlm. nih.gov/pubmed/33028588 (дата обращения: 08.01.2021).
46. MacInnis M.J., Gibala M.J. Physiological adaptations to interval training and the role of exercise intensity. J Physiol. 2017 May 1;595(9):2915–2930. doi: 10.1113/ JP273196. www.ncbi.nlm.nih.gov/pubmed/27748956 (дата обращения: 10.03.2021).